Literature DB >> 14202182

DIPHENYLHYDANTOIN AND PHENOBARBITAL TOXICITY. THE ROLE OF LIVER DISEASE.

H KUTT, W WINTERS, R SCHERMAN, F MCDOWELL.   

Abstract

Entities:  

Keywords:  ATAXIA; BARBITURATE TOXICOLOGY; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY; DIPHENYLHYDANTOIN; DRUG TOLERANCE; HEPATITIS, INFECTIOUS; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER FUNCTION TESTS; METABOLISM; NYSTAGMUS; PHENOBARBITAL; SPECTROPHOTOMETRY; TOXICOLOGIC REPORT; URINE

Mesh：

Substances：

Year:  1964        PMID： 14202182     DOI： 10.1001/archneur.1964.00460240081011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  17 in total

1.  The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.

Authors:  E H Reynolds
Journal:  Proc R Soc Med       Date:  1975-02

2.  [Drug therapy of tachyarrhythmias (author's transl)].

Authors:  K Theisen
Journal:  Klin Wochenschr       Date:  1978-02-15

Review 3.  Guide to drug dosage in hepatic disease.

Authors:  N M Bass; R L Williams
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

4.  [Control of long-term therapy with diphenylhydantoin. Gas-chromatographic determination of diphenylhydantoin and hydroxy-diphenylhydantoin].

Authors:  J Mascher; W Bernhardt
Journal:  Z Neurol       Date:  1973-05-17

Review 5.  Psychiatric aspects of epilepsy.

Authors:  D F Scott
Journal:  Postgrad Med J       Date:  1968-04       Impact factor: 2.401

6.  [Changes in the velocity of drug catabolism and their importance in drug therapy].

Authors:  G F Kahl
Journal:  Klin Wochenschr       Date:  1971-04-01

7.  Delayed phenytoin idiosyncrasy.

Authors:  S Behrman
Journal:  Br Med J       Date:  1969-11-22

8.  [Pharmacokinetics of meprobamate in chronic liver diseases and drug addiction].

Authors:  H Held; H F von Oldershausen
Journal:  Klin Wochenschr       Date:  1969-01-15

9.  [Influence of liver diseases and kidney function disorders and phenylbutazone, phenprocoumarol and doxycycline on the excretion of glycodiazine].

Authors:  H Held; B Kaminski; H F von Oldershausen
Journal:  Diabetologia       Date:  1970-08       Impact factor: 10.122

Review 10.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.